Laurion Capital Management LP Ascendis Pharma A/S Transaction History

Laurion Capital Management LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $619,877 - $933,705	-7,939 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $811,207 - $1.08 Million	7,939 New	7,939 $932,000
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $2.33 Million - $3.66 Million	-20,699 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $2.52 Million - $3.01 Million	20,699 New	20,699 $2.72 Million
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $982,799 - $1.19 Million	-6,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$134.29 - $154.32 $25,515 - $29,320	-190 Reduced 2.84%	6,500 $1 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $741,720 - $1.04 Million	6,690 New	6,690 $989,000
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $882,791 - $1.32 Million	-9,100 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$91.45 - $139.12 $464,383 - $706,451	5,078 Added 126.26%	9,100 $1.27 Million
Q3 2019 Nov 13, 2019	SELL	$95.8 - $118.9 $1.17 Million - $1.45 Million	-12,210 Reduced 75.22%	4,022 $387,000
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $1.74 Million - $2.14 Million	16,232 New	16,232 $1.87 Million
Q1 2018 May 14, 2018	SELL	$38.98 - $68.04 $2.14 Million - $3.74 Million	-54,952 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$31.98 - $40.38 $7.3 Million - $9.22 Million	-228,378 Reduced 80.6%	54,952 $2.2 Million
Q3 2017 Nov 13, 2017	BUY	$26.89 - $37.1 $7.62 Million - $10.5 Million	283,330	283,330 $10.3 Million

236

59.6M

108K

234K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.04B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.